These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 980096)

  • 1. Primary pulmonary hypertension; favorable effect of isoproterenol.
    Shettigar UR; Hultgren HN; Specter M; Martin R; Davies DH
    N Engl J Med; 1976 Dec; 295(25):1414-5. PubMed ID: 980096
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension.
    Daoud FS; Reeves JT; Kelly DB
    Am J Cardiol; 1978 Nov; 42(5):817-22. PubMed ID: 707294
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary pulmonary hypertension in a child. Response to pharmacologic agents.
    Satyanarayana Rao BN; Moller JH; Edwards JE
    Circulation; 1969 Oct; 40(4):583-7. PubMed ID: 5823553
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual isoprenaline in treatment of primary pulmonary hypertension: discussion paper.
    Ackroyd JF
    J R Soc Med; 1985 Jun; 78(6):474-7. PubMed ID: 3999084
    [No Abstract]   [Full Text] [Related]  

  • 5. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S; Martinez J; Lam W; Levy PS; Rosen KM
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract]   [Full Text] [Related]  

  • 6. Isoproterenol in primary pulmonary hypertension.
    Pantano JA
    N Engl J Med; 1980 Apr; 302(16):919-20. PubMed ID: 7360180
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary vascular resistance in neonatal swine: response to right pulmonary artery occlusion, isoproterenol, and prostaglandin E1.
    Crombleholme TM; Adzick NS; Longaker MT; Bradley SM; Duncan BW; Jennings R; Verrier ED; Harrison MR
    J Pediatr Surg; 1990 Aug; 25(8):861-6. PubMed ID: 2401941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of canine pulmonary hypertension: effects of norepinephrine and isoproterenol on pulmonary vascular pressure-flow characteristics.
    Ducas J; Duval D; Dasilva H; Boiteau P; Prewitt RM
    Circulation; 1987 Jan; 75(1):235-42. PubMed ID: 3791605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasodilators on pulmonary vascular resistance in patients with pulmonary hypertension.
    Zaloga GP; Chernow B; Holt MR; Hughes P; Pilley MP; Rainey TG; Lake CR
    Clin Pharm; 1983; 2(3):265-8. PubMed ID: 6192967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodynamic justification of continuous flow technics for catecholamine infusion in circulatory distress].
    Chausset B; Racle JP; Belin M; Constantin B
    Anesth Analg (Paris); 1977; 34(6):1223-37. PubMed ID: 350090
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoproterenol in massive pulmonary embolism: haemodynamic and clinical effects.
    McDonald IG; Hirsh J; Hale GS; Cade JF; McCarthy RA
    Med J Aust; 1968 Aug; 2(5):201-5. PubMed ID: 5676200
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary pulmonary hypertension and pregnancy: anesthetic management for delivery.
    Slomka F; Salmeron S; Zetlaoui P; Cohen H; Simonneau G; Samii K
    Anesthesiology; 1988 Dec; 69(6):959-61. PubMed ID: 3195768
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of isoproterenol in pulmonary artery hypertension of unknown etiology (primary): short- and long-term evaluation.
    Lupi-Herrera E; Bialostozky D; Sobrino A
    Chest; 1981 Mar; 79(3):292-6. PubMed ID: 7471861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension during systemic hypotension. Effects of oxygen breathing and of vasodilators.
    Bo G; Hauge A; Hognestad J
    Acta Physiol Scand; 1972 Dec; 86(4):466-73. PubMed ID: 4640285
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
    Prielipp RC; McLean R; Rosenthal MH; Pearl RG
    Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual isoproterenol for primary pulmonary hypertension.
    Hogan RA
    N Engl J Med; 1984 Aug; 311(8):538. PubMed ID: 6749216
    [No Abstract]   [Full Text] [Related]  

  • 17. Left ventricular performance during the infusion of isoproterenol in patients with valvular heart diseases and idiopathic cardiomegaly.
    Ueda H; Machida K; Nakanishi A; Ito I; Yasuda H
    Jpn Heart J; 1968 May; 9(3):228-40. PubMed ID: 4235492
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
    Jewitt D; Birkhead J; Mitchell A; Dollery C
    Lancet; 1974 Aug; 2(7877):363-7. PubMed ID: 4136593
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary pulmonary hypertension. Responses to indomethacin, terbutaline, and isoproterenol.
    Person B; Proctor RJ
    Chest; 1979 Nov; 76(5):601-3. PubMed ID: 498836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of intrahepatic vasculature to isoproterenol and epinephrine influsions.
    Hanson KM
    Angiologica; 1973; 10(2):65-75. PubMed ID: 4721153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.